Haemorrhoid Relief Sainsburys (Allantoin, Lidocaine Hydrochloride)

Haemorrhoid Relief Sainsbury's is indicated for the symptomatic management of external hemorrhoidal conditions, providing topical analgesia and skin protection during episodes of pain, itching, or mild irritation.

• Alleviates mild to moderate hemorrhoid pain by numbing the affected area with lidocaine.
• Decreases anal itching and burning sensations associated with hemorrhoidal inflammation.
• Provides temporary soothing after bowel movements, reducing discomfort during daily activities.
• Assists in the care of minor skin irritation or fissures around the anal margin.
• Supports the natural repair process of the skin through the action of allantoin.

The safety profile of Haemorrhoid Relief Sainsbury's reflects the typical effects of topical lidocaine and allantoin preparations, which are generally well tolerated when applied to intact skin.

Common

• Mild transient burning, stinging, or tingling at the site of application, usually resolving within minutes.
• Slight redness or erythema of the surrounding skin that diminishes with continued use.
• Temporary sensation of numbness limited to the area where the product is applied.
• Minor skin dryness, flaking, or peeling after repeated applications.

Serious

• Allergic skin reaction such as rash, swelling, hives, or contact dermatitis requiring medical attention.
• Persistent numbness, weakness, or loss of sensation that spreads beyond the treated region.

When using Haemorrhoid Relief Sainsbury's, certain precautions help minimize risks and ensure effective symptom control.

• Apply only to intact, non‑broken skin around the anal area.
• Avoid contact with eyes, mucous membranes, or open wounds.
• Do not use under occlusive dressings unless advised by a healthcare professional.
• Limit the amount applied; excessive use may increase systemic lidocaine absorption.
• Stop use and seek medical advice if rash, persistent numbness, or severe irritation develops.

Haemorrhoid Relief Sainsbury's may interact with other topical or systemic agents; awareness of these interactions helps maintain safety.

Avoid

• Concurrent use of other topical anesthetics containing lidocaine or similar agents, which could increase total local anesthetic exposure.

Use with caution

• Application together with strong corticosteroid creams, as skin barrier changes may alter absorption.
• Use in patients taking oral antiarrhythmic drugs (e.g., class I agents) because systemic lidocaine levels could be additive.
• Combine with other skin‑protective products containing allantoin only if tolerated, monitoring for additive irritation.